Vicarious Surgical Inc. ( (RBOT) ) has released its Q2 earnings. Here is a breakdown of the information Vicarious Surgical Inc. presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Vicarious Surgical Inc., a pioneering company in the field of robotic surgery, is focused on enhancing surgical procedures through innovative technology. The company, based in Waltham, Massachusetts, aims to improve patient outcomes and reduce healthcare costs with its human-like surgical robots.
In the second quarter of 2025, Vicarious Surgical reported a decrease in operating expenses and a reduction in net loss compared to the previous year. The company also announced a leadership change, with Stephen From stepping into the role of CEO, bringing his experience to guide the company through its next phase of growth.
Key financial highlights include a 24% decrease in operating expenses, totaling $13.5 million, and a reduction in R&D expenses to $9.1 million. The company’s net loss for the quarter was $13.2 million, or $2.23 per share, showing improvement from the previous year’s loss. Vicarious Surgical ended the quarter with $24 million in cash and investments.
Looking ahead, Vicarious Surgical anticipates a cash burn of approximately $50 million for the full year 2025. The company’s management remains optimistic about the potential of its technology to transform surgical care and is focused on executing its strategic vision to unlock further growth opportunities.